Georgetown University Hospital/Lombardi Cancer Center

Washington D.C., District of Columbia 20007-2197

0 studies enrolling now · 5 studies all time

What they study most

Angioedema, Chronic Lymphocytic Leukemia, Chronic Lymphocytic Lymphoma, Kidney Neoplasms, Non-Hodgkin's Lymphoma, Pancreas Cancer

Studies at this site

• Phase I/II Study of Different Doses and Dose Schedules of Milatuzumab (hLL1) in CLL — Completed
• Subcutaneous Treatment With Icatibant for Acute Attacks of Hereditary Angioedema — Completed
• Axitinib (AG 013736) As Second Line Therapy For Metastatic Renal Cell Cancer — Completed
• Study of Pemetrexed for Second-Line Pancreas Cancer — Stopped early
• Trial of Bendamustine, Lenalidomide and Rituximab in Chronic Lymphocytic Leukemia (CLL) and Non-Hodgkin's Lymphoma (NHL) — Completed